CrestPoint Capital Management’s Labcorp LH Stock Holding History

CrestPoint Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,190	Closed	-$543K	–	206
2017 Q3	$543K	Hold	4,190	–	–	0.24%	140
2017 Q2	$555K	Hold	4,190	–	–	0.26%	131
2017 Q1	$516K	Sell	4,190 -117	-3%	-$13.9K	0.25%	132
2016 Q4	$475K	Hold	4,307	–	–	0.24%	139
2016 Q3	$509K	Hold	4,307	–	–	0.26%	129
2016 Q2	$482K	Hold	4,307	–	–	0.26%	132
2016 Q1	$433K	Sell	4,307 -5,121	-54%	-$491K	0.24%	137
2015 Q4	$1M	Hold	9,428	–	–	0.57%	58
2015 Q3	$879K	Buy	9,428 +4,656	+98%	+$482K	0.5%	74
2015 Q2	$497K	Buy	4,772 +108	+2%	+$11.2K	0.26%	134
2015 Q1	$505K	Buy	4,664 +124	+3%	+$12.8K	0.26%	134
2014 Q4	$421K	Hold	4,540	–	–	0.23%	150
2014 Q3	$397K	Buy	+4,540	New	+$410K	0.24%	143

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CrestPoint Capital Management's LH Position: Q4 2017 in Review

CrestPoint Capital Management sold out of Labcorp (LH) in Q4 2017, closing a stake of 4,190 shares — an estimated $543K sold.

CrestPoint Capital Management first reported a position in LH in Q3 2014 and held it in 13 quarters. The position peaked at $1M in Q4 2015. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

CrestPoint Capital Management reported no remaining Labcorp position as of Q4 2017 after selling out during the quarter.
CrestPoint Capital Management sold 4,190 Labcorp shares in Q4 2017, an estimated $543K.
CrestPoint Capital Management first reported a position in Labcorp in Q3 2014 and held it in 13 quarters.
CrestPoint Capital Management's Labcorp position peaked at $1M in Q4 2015.
753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.